Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction

Comparable effect of tolvaptan in heart failure patients with preserved or reduced ejection fraction

Background: It is unclear that the difference in efficacy of tolvaptan (TLV) on the length of hospital stay for both heart failure (HF) preserved ejection fraction (EF) (HFpEF) and reduced EF (HFrEF) patients. Methods: We investigated 369 patients who were hospitalized with HF from February 2011 to...

Full description

Bibliographic Details
Main Authors: Shunsuke Kiuchi, Shinji Hisatake, Takayuki Kabuki, Takashi Oka, Shintaro Dobashi, Takahiro Fujii, Takanori Ikeda
Format: Article
Language:English
Published: Taylor & Francis Group 2020-02-01
Series:Clinical and Experimental Hypertension
Subjects:
tolvaptan
the length of hospital stay
heart failure
reduced ejection fraction
preserved ejection fraction
Online Access:http://dx.doi.org/10.1080/10641963.2019.1583244

Similar Items

Similar Items